Radium-223 for the Management of Bone Metastases in Castration-Resistant Prostate Cancer

Journal of the Advanced Practitioner in Oncology
doi 10.6004/jadpro.6.6.5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Harborside Press, LLC

Related search

Treatment of Castration-Resistant Prostate Cancer and Bone Metastases With Radium-223 Dichloride

International Journal of Urological Nursing
UrologyNursingNephrology
2014English

Radium-223 for the Treatment of Patients With Castration-Resistant Prostate Cancer With Bone Metastases

Medical Council
2018English

The Contemporary Use of Radium-223 in Metastatic Castration Resistant Prostate Cancer

Clinical Genitourinary Cancer
OncologyUrology
2018English

Evaluating Radium-223 Response in Metastatic Castration-Resistant Prostate Cancer With Imaging

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2018English

Importance of the Correct Assessment of Bone Fractures in the Clinical Management of Metastatic Castration‑resistant Prostate Cancer Treated With Radium‑223: A Case Report

Molecular and Clinical Oncology
Cancer ResearchOncology
2019English

Pain, PSA Flare, and Bone Scan Response in a Patient With Metastatic Castration-Resistant Prostate Cancer Treated With Radium-223, a Case Report

BMC Cancer
Cancer ResearchOncologyGenetics
2015English

Platelet-Derived Growth Factor Receptor Inhibition and Chemotherapy for Castration-Resistant Prostate Cancer With Bone Metastases

Clinical Cancer Research
Cancer ResearchOncology
2007English

Radium-223 Therapy of Advanced Metastatic Castration-Resistant Prostate Cancer: Quantitative Assessment of Skeletal Tumor Burden for Prognostication of Clinical Outcome and Hematological Toxicity

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2017English

Clinical Concepts for Cabazitaxel in the Management of Metastatic Castration‐resistant Prostate Cancer

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy